Israel's low investment in health in general, and in public health in particular, causes national health spending in Israel (including public and private spending) to be 7.5% of GDP alone, compared to an average of 8.8% in the OECD, with public funding only about 60% of expenditure. In most OECD countries public funding is higher.
Obesity, an increase in diabetes morbidity and opiate drug consumption have led to a decline in life expectancy in 19 OECD countries (Organization of Developed Countries) in 2015, as well as a slowdown in life expectancy in Israel, according to a new OECD report, "A Look at Health," which works By the Central Bureau of Statistics (CBS) and published today.
According to the report, life expectancy in all countries of the organization has increased dramatically since 1970 and is now almost 81 years. However, in recent years there has been a marked slowdown in life expectancy in some countries, especially in the US, France and the Netherlands.
In 2015, life expectancy even decreased in 19 countries, including Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Netherlands, Poland, Slovakia, Slovenia, Spain, Switzerland, United Kingdom, USA. "In Israel, too. The researchers explain that this is a specific case for this year.
While Israel stands out favorably in comparison to the other countries with the high life expectancy of its citizens, 82.6 years - a higher figure than the OECD average, but in our report, too, "in recent years there has been a slowdown in the rate of increase in life expectancy". The highest life expectancy is attributed to Japan (84.2) and then Switzerland (83.6).
The reasons for the slowdown in life expectancy are, among other things, an increase in obesity and diabetes, which has led to more morbidity from heart disease and stroke, compared to the past. In addition, according to the report and CBS, "respiratory illnesses such as influenza and pneumonia have caused more deaths in recent years than before, especially among the elderly."
In Israel, diabetes rates and obesity rates (among children) are relatively high: almost 7% of adults in diabetes suffer from diabetes, more than the OECD average (which is 6.4%), while in Mexico, Turkey and the United States the highest rates of morbidity; in Ireland, Lithuania and Estonia In Israel, the proportion of overweight or obese adults (51%) is slightly lower than the OECD average (which is 56%), but among children aged 5-9, the ratio is 38% higher than the average, compared to 33%.
The growth in life expectancy may also be associated with an increase in mortality from opiate drug use - addictive drugs between their side effects and apnea, which can also lead to death from over-consumption (overdose). According to the report, since 2011, opioid mortality has risen by an average of more than 20% in organization countries, causing the deaths of only 400,000 in the US. Opioid mortality is also relatively high in Canada, Estonia and Sweden. In Israel, opioid use has increased in recent years, alongside the UK and the Netherlands. , But there is still no significant expression of mortality.
As far as smoking is concerned, smoking rates in the OECD countries are noticeable, but they are still high: 18% of those aged 15 and over smoke daily. In Israel, 17% of people aged 15 and over smoke daily - 21.3% of men, compared to 12.8% of women. Indonesia, Russia and Greece have the highest smoking rates; And in Costa Rica, Mexico and Iceland are the lowest. The percentage of alcohol consumption in Israel is among the lowest among the organization's countries.
The report also points to Israel's low investment in health in general, and public health in particular: Today, national health expenditure in Israel (including public and private expenditure) is 7.5% of GDP alone, compared to an average of 8.8% in the OECD, with public funding around 60 In most OECD countries, public funding is higher.
By 2030, national health spending in Israel is expected to grow to 8.8% of GDP, and will still be one of the lowest in the organization. In the next 15 years, health spending is expected to grow more than GDP growth in most OECD countries.
The highest expenditure on health in 2018 was in the US - 16.9% of GDP, followed by Switzerland with 12.2% of GDP. Health expenditure in Germany, France, Sweden and Japan was close to 11% of GDP. In some countries, health expenditure was less than 6% of GDP, including Mexico, Latvia, Luxembourg and Turkey, with the lowest expenditure being 4.2% of GDP.
It is also becoming clear that the health care system and social services in OECD countries now employ more workers than ever before. About a tenth of all jobs are in health or social services. According to the report, "Transferring tasks from physicians to nurses and other healthcare professionals (e.g. nurses and physician assistants, HW) can alleviate the financial burden and improve efficiency."
In Israel, the problem of older doctors is evident, and it is currently peak (second only to Italy) in older doctors, aged 55 plus, with about half of the doctors present at these ages. The problem lies in the fact that these doctors are expected to retire in the coming years, and there will not be enough young doctors to take their place.